BE534664A - - Google Patents
Info
- Publication number
- BE534664A BE534664A BE534664DA BE534664A BE 534664 A BE534664 A BE 534664A BE 534664D A BE534664D A BE 534664DA BE 534664 A BE534664 A BE 534664A
- Authority
- BE
- Belgium
- Prior art keywords
- volume
- weight
- compositions according
- ethanol
- anesthetic compositions
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 18
- 230000003444 anaesthetic effect Effects 0.000 claims description 12
- 235000019441 ethanol Nutrition 0.000 claims description 8
- BQPBZDSDFCDSAO-UHFFFAOYSA-N 2-naphthalen-2-yloxyethanol Chemical compound C1=CC=CC2=CC(OCCO)=CC=C21 BQPBZDSDFCDSAO-UHFFFAOYSA-N 0.000 claims description 7
- -1 cyclohexen-2-yl Chemical group 0.000 claims description 7
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000004215 Carbon black (E152) Substances 0.000 claims description 6
- 229930195733 hydrocarbon Natural products 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 150000007656 barbituric acids Chemical class 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- DNZPLHRZXUJATK-UHFFFAOYSA-N 2-sulfanylidene-5-[[5-[2-(trifluoromethyl)phenyl]furan-2-yl]methyl]-1,3-diazinane-4,6-dione Chemical compound FC(F)(F)C1=CC=CC=C1C(O1)=CC=C1CC1C(=O)NC(=S)NC1=O DNZPLHRZXUJATK-UHFFFAOYSA-N 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 description 6
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 6
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 239000003193 general anesthetic agent Substances 0.000 description 2
- 229920001281 polyalkylene Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- SGKUPLCQYHQBTN-UHFFFAOYSA-N 1-ethyl-1,3-diazinane-2,4,6-trione Chemical compound CCN1C(=O)CC(=O)NC1=O SGKUPLCQYHQBTN-UHFFFAOYSA-N 0.000 description 1
- VZLMIORNRMGZJC-UHFFFAOYSA-N 1-naphthalen-2-yloxyethanol Chemical compound C1=CC=CC2=CC(OC(O)C)=CC=C21 VZLMIORNRMGZJC-UHFFFAOYSA-N 0.000 description 1
- QSELDKYOARDOCZ-UHFFFAOYSA-N 5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound CCCC(C)C1C(=O)NC(=O)NC1=O QSELDKYOARDOCZ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE534664A true BE534664A (enrdf_load_stackoverflow) |
Family
ID=165941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE534664D BE534664A (enrdf_load_stackoverflow) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE534664A (enrdf_load_stackoverflow) |
-
0
- BE BE534664D patent/BE534664A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1131710C (zh) | 皮肤水化能力提高的皮肤护理组合物 | |
FR2774595A1 (fr) | Emulsion pour l'administration transdermique de steroides | |
EP0334777B1 (fr) | Microémulsion à usage cosmétique ou pharmaceutique | |
LU88114A1 (fr) | Nouvelles compositions pharmaceutiques pour application locale | |
CA1341273C (fr) | Systeme anti-oxydant a base d'un ester d'ascorbyle stabilise et compositions contenant un tel systeme anti-oxydant | |
JP2012505171A (ja) | 皮膚または膣粘膜へ適用するための徐放性エマルジョン | |
EP1885374A2 (fr) | Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise | |
EP0309353B1 (fr) | Composition de traitement de la peau sous forme de mousse aérosol contenant de la vaseline | |
EP0737062A1 (fr) | Lotion eau dans huile contenant du corticosteroide | |
LU87681A1 (fr) | Compositions pharmaceutiques | |
WO2000017294A1 (fr) | Concentre hydrosoluble obtenu a partir d'une phase emulgatrice ou hydrosolubilisante et d'un complexe de matieres lipophiles liquides d'origine vegetale | |
CH644758A5 (fr) | Composition aqueuse stable a base de peroxyde de benzoyle. | |
LU83126A1 (fr) | Composition de savon liquide | |
CZ10295A3 (en) | Topic anti-inflammatory preparation based on piroxicam and method of solubilizing piroxicam | |
BE534664A (enrdf_load_stackoverflow) | ||
EP3200760B1 (fr) | Composition cosmétique et/ou pharmaceutique sous forme de dispersion, procédé de préparation et utilisation pour le traitement de la peau | |
HUE027718T2 (en) | Oil-in-water emulsion containing mometasone and propylene glycol | |
FR2549848A1 (fr) | Compositions de savon | |
BE1011216A3 (fr) | Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition. | |
FR2663847A1 (fr) | Composition cosmetique comportant une phase grasse et une phase hydrosoluble, l'une desdites phases contenant au repos une microemulsion. | |
EP3189827B1 (fr) | Formulation aqueuse comprenant une composition lipophile comprenant de la cellulose et de l'argile | |
CA2684126A1 (fr) | Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques | |
KR102752826B1 (ko) | 멘톨계 및 비멘톨계 냉감제를 고함량 포함하는 투명 가용화 화장료 조성물 | |
CA1117236A (fr) | Emulsions du type "eau-dans-l'huile" et produits cosmetiques les contenant | |
WO2025132038A2 (fr) | Composition cosmetique comprenant un complexe antimicrobien synergique |